Lalia Capital LLC Takes Position in SPDR S&P Biotech ETF $XBI

Lalia Capital LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 100,000 shares of the exchange traded fund’s stock, valued at approximately $12,193,000. SPDR S&P Biotech ETF accounts for 9.5% of Lalia Capital LLC’s investment portfolio, making the stock its 4th largest holding.

Other institutional investors have also recently made changes to their positions in the company. Legacy Wealth Managment LLC ID acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000. Ballast Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $36,000. Creative Financial Designs Inc. ADV acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $39,000. MCF Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $46,000. Finally, Barnes Dennig Private Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $48,000.

SPDR S&P Biotech ETF Trading Down 3.6%

Shares of NYSEARCA XBI opened at $128.67 on Friday. The firm’s 50-day moving average price is $131.90 and its 200-day moving average price is $126.56. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $139.19. The firm has a market capitalization of $8.21 billion, a P/E ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.